Table 3.
Factors that may influence the implementation of reliable VCTE.
| Reliable examinations (n = 163) | Unreliable examinations (n = 25) | P-value | |
|---|---|---|---|
| Age, years | 59.7 ± 13.0 | 60.6 ± 13.7 | 0.75 |
| Sex, male:female | 86:77 | 10:15 | 0.24 |
| Height, m | 1.6 ± 0.10 | 1.60 ± 0.1 | 0.38 |
| Body weight, kg | 75.1 ± 15.5 | 71.90 ± 13.3 | 0.32 |
| BMI, kg/m2 | 28.5 ± 4.5 | 28.0 ± 5.4 | 0.67 |
| PCD mm | 22.5 ± 4.9 | 22.9 ± 5.2 | 0.71 |
| LSM, utilizing MRE | 11.9 ± 7.7 | 4.4 ± 1.6 | 0.88 |
| MRI-PDFF, utilizing MRI | 11.7 ± 7.0 | 10.2 ± 4.4 | 0.28 |
| Fibrosis stage | 2.4 ± 1.1 | 2.2 ± 1.0 | 0.44 |
| Steatosis grade | 1.6 ± 0.8 | 1.5 ± 0.7 | 0.48 |
Data are presented as means ± standard deviations.
BMI body mass index, LSM liver stiffness measurement, MRE magnetic resonance elastography, MRI magnetic resonance imaging, MRI-PDFF magnetic resonance imaging-proton density fat fraction, PCD probe to liver capsule distance.
*P < 0.05.